FAC MEDICINA
Centro
Yale School of Medicine
New Haven, Estados UnidosPublicaciones en colaboración con investigadores/as de Yale School of Medicine (20)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
MIF is a common genetic determinant of COVID-19 symptomatic infection and severity
QJM : monthly journal of the Association of Physicians, Vol. 116, Núm. 3, pp. 205-212
2022
-
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design
American Heart Journal, Vol. 246, pp. 32-43
-
One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry
PLoS ONE, Vol. 17, Núm. 12 December
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
-
The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors
Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 838-851
2021
-
Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic
Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 542-552
-
Mitochondrial cristae-remodeling protein OPA1 in POMC neurons couples Ca2+ homeostasis with adipose tissue lipolysis
Cell Metabolism, Vol. 33, Núm. 9, pp. 1820-1835.e9
2020
-
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Nature Communications, Vol. 11, Núm. 1
-
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (Nature Communications, (2020), 11, 1, (3819), 10.1038/s41467-020-17644-0)
Nature Communications
2014
-
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS Genetics, Vol. 10, Núm. 4
2010
-
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction
Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754
2007
-
Hypoxia transduction by carotid body chemoreceptors in mice lacking dopamine D2 receptors
Journal of Applied Physiology, Vol. 103, Núm. 4, pp. 1269-1275
2003
-
ras Mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer
Journal of Clinical Oncology, Vol. 21, Núm. 17, pp. 3226-3235
2002
-
RET activation and clinicopathologic features in poorly differentiated thyroid tumors
Journal of Clinical Endocrinology and Metabolism, Vol. 87, Núm. 1, pp. 370-379
2000
-
Single-unit recordings of arterial chemoreceptors from mouse petrosal ganglia in vitro
Journal of Applied Physiology, Vol. 88, Núm. 4, pp. 1489-1495
1999
-
Downregulation of p27(KIP1) and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories
American Journal of Surgical Pathology, Vol. 23, Núm. 6, pp. 678-685
-
Frequent chromosomal DNA unbalance in thyroid oncocytic (Hurthle cell) neoplasms detected by comparative genomic hybridization
Laboratory Investigation, Vol. 79, Núm. 5, pp. 547-555
-
Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma
Cancer Research, Vol. 59, Núm. 8, pp. 1811-1815